SCHEMBL1710893

SCHEMBL1710893

Oc1cc(Br)cc(I)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL309955 0.78
SCHEMBL782213 0.78
SCHEMBL69898 0.78
SCHEMBL1687060 0.78
SCHEMBL69370 0.78
SCHEMBL1229565 0.78
SCHEMBL27936424 0.76 CYP3A4 (0.47)
SCHEMBL9397842 0.76 TTR (0.33)
SCHEMBL1071522 0.67 ACHE (0.39)
SCHEMBL11568821 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12415783-B2 Compound for organic electric element, organic electric element using same, and electronic apparatus thereof DUK SAN NEOLUX CO., LTD. (KR) 2025-09-16 US disclosed
WO-2025021182-A1 CYP11A1 INHIBITORS ACERAND THERAPEUTICS (HONG KONG) LIMITED (CN) 2025-01-30 WO disclosed
CN-119320342-A Method for preparing disulfide at low temperature 苏州大学 2025-01-17 CN disclosed
CN-118184669-A Macrocyclic compounds as multi-target kinase inhibitors 北京伯汇生物技术有限公司 2024-06-14 CN disclosed
CN-112106215-B Compound for organic electric element, organic electric element using the same, and electronic device using the same 德山新勒克斯有限公司 2023-12-12 CN disclosed
US-20210340103-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS THEREOF DUK SAN NEOLUX CO., LTD (KR) 2021-11-04 US disclosed
WO-2021113698-A1 MASP-2 INHIBITORS AND METHODS OF USE OMEROS CORPORATION (US) 2021-06-10 WO disclosed
US-11020381-B2 Biaryloxy derivatives as TTX-S blockers RAQUALIA PHARMA INC. (JP) 2021-06-01 US disclosed
CN-112106215-A Compound for organic electric element, organic electric element using the same, and electronic device thereof 德山新勒克斯有限公司 2020-12-18 CN disclosed
US-20200230123-A1 BIARYLOXY DERIVATIVES AS TTX-S BLOCKERS RAQUALIA PHARMA INC. (JP) 2020-07-23 US disclosed
US-20080300298-A1 Honokiol Derivates For the Treatment of Proliferative Disorders NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-12-04 US disclosed
US-20080300298-A1 Honokiol Derivates For the Treatment of Proliferative Disorders NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-12-04 US disclosed
US-20080300298-A1 Honokiol Derivates For the Treatment of Proliferative Disorders NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-12-04 US disclosed
US-20080280891-A1 Anti-cancer agents and uses thereof LOCUS PHARMACEUTICALS, INC. (US) 2008-11-13 US disclosed
WO-2008008059-A1 ANTI-CANCER AGENTS ANS USES THEREOF LOCUS PHARMACEUTICALS, INC. (US) 2008-01-17 WO disclosed
EP-1853539-A2 HONOKIOL DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Arbiser, Jack (US) 2007-11-14 EP disclosed
US-20060270686-A1 Anti-cancer agents and uses thereof LOCUS PHARMACEUTICALS, INC. 2006-11-30 US disclosed
WO-2006107451-A2 HONOKIOL DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISORDERS UNIV EMORY (US) 2006-10-12 WO disclosed
US-6828466-B2 Reacting arene with borane; oxidation, hydrogenation phenylboronic acid BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2004-12-07 US disclosed
US-20040030197-A1 Process for the synthesis of phenols from arenes BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2004-02-12 US disclosed